nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—FDX1—Endogenous sterols—CYP1B1—glaucoma	0.0111	0.114	CbGpPWpGaD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00979	0.1	CbGpPWpGaD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00668	0.0683	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00517	0.0529	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00419	0.0429	CbGpPWpGaD
Mitotane—CYP11B1—Endogenous sterols—CYP1B1—glaucoma	0.00397	0.0406	CbGpPWpGaD
Mitotane—CYP11A1—Endogenous sterols—CYP1B1—glaucoma	0.0034	0.0347	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTT1—glaucoma	0.0028	0.0286	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP1B1—glaucoma	0.00223	0.0228	CbGpPWpGaD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.00222	0.0227	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00208	0.0213	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NARFL—glaucoma	0.00196	0.02	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CA5A—glaucoma	0.00196	0.02	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00184	0.0188	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00182	0.0186	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTM1—glaucoma	0.00178	0.0182	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00158	0.0161	CbGpPWpGaD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00156	0.0159	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00149	0.0153	CbGpPWpGaD
Mitotane—Pain—Apraclonidine—glaucoma	0.00128	0.00142	CcSEcCtD
Mitotane—Dyspepsia—Bimatoprost—glaucoma	0.00128	0.00142	CcSEcCtD
Mitotane—Infection—Brimonidine—glaucoma	0.00128	0.00142	CcSEcCtD
Mitotane—Hypertension—Brinzolamide—glaucoma	0.00128	0.00142	CcSEcCtD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00128	0.0131	CbGpPWpGaD
Mitotane—Nausea—Carteolol—glaucoma	0.00127	0.00141	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00127	0.00141	CcSEcCtD
Mitotane—Headache—Levobunolol—glaucoma	0.00127	0.00141	CcSEcCtD
Mitotane—Shock—Brimonidine—glaucoma	0.00127	0.00141	CcSEcCtD
Mitotane—Infestation NOS—Betaxolol—glaucoma	0.00127	0.00141	CcSEcCtD
Mitotane—Infestation—Betaxolol—glaucoma	0.00127	0.00141	CcSEcCtD
Mitotane—Nervous system disorder—Brimonidine—glaucoma	0.00126	0.0014	CcSEcCtD
Mitotane—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00126	0.00139	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00125	0.00139	CcSEcCtD
Mitotane—Skin disorder—Brimonidine—glaucoma	0.00125	0.00139	CcSEcCtD
Mitotane—Nausea—Diclofenamide—glaucoma	0.00125	0.00139	CcSEcCtD
Mitotane—Pain—Bimatoprost—glaucoma	0.00125	0.00138	CcSEcCtD
Mitotane—Dizziness—Latanoprost—glaucoma	0.00124	0.00138	CcSEcCtD
Mitotane—Confusional state—Dorzolamide—glaucoma	0.00124	0.00138	CcSEcCtD
Mitotane—Feeling abnormal—Apraclonidine—glaucoma	0.00124	0.00137	CcSEcCtD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.00124	0.0126	CbGpPWpGaD
Mitotane—Vomiting—Methazolamide—glaucoma	0.00123	0.00137	CcSEcCtD
Mitotane—Hypertension—Pilocarpine—glaucoma	0.00123	0.00136	CcSEcCtD
Mitotane—Rash—Methazolamide—glaucoma	0.00122	0.00136	CcSEcCtD
Mitotane—Dermatitis—Methazolamide—glaucoma	0.00122	0.00136	CcSEcCtD
Mitotane—Eye disorder—Clonidine—glaucoma	0.00122	0.00136	CcSEcCtD
Mitotane—Nausea—Carbachol—glaucoma	0.00122	0.00135	CcSEcCtD
Mitotane—Infection—Travoprost—glaucoma	0.00122	0.00135	CcSEcCtD
Mitotane—Headache—Methazolamide—glaucoma	0.00122	0.00135	CcSEcCtD
Mitotane—Breast disorder—Timolol—glaucoma	0.00122	0.00135	CcSEcCtD
Mitotane—Shock—Dorzolamide—glaucoma	0.00121	0.00134	CcSEcCtD
Mitotane—Paraesthesia—Acetazolamide—glaucoma	0.00121	0.00134	CcSEcCtD
Mitotane—Hypotension—Brimonidine—glaucoma	0.00121	0.00134	CcSEcCtD
Mitotane—Nausea—Levobunolol—glaucoma	0.0012	0.00133	CcSEcCtD
Mitotane—Infection—Brinzolamide—glaucoma	0.0012	0.00133	CcSEcCtD
Mitotane—Nervous system disorder—Travoprost—glaucoma	0.0012	0.00133	CcSEcCtD
Mitotane—Somnolence—Acetazolamide—glaucoma	0.00119	0.00132	CcSEcCtD
Mitotane—Skin disorder—Travoprost—glaucoma	0.00119	0.00132	CcSEcCtD
Mitotane—Nervous system disorder—Brinzolamide—glaucoma	0.00119	0.00132	CcSEcCtD
Mitotane—Angiopathy—Clonidine—glaucoma	0.00119	0.00132	CcSEcCtD
Mitotane—Rash—Latanoprost—glaucoma	0.00118	0.00131	CcSEcCtD
Mitotane—Dermatitis—Latanoprost—glaucoma	0.00118	0.00131	CcSEcCtD
Mitotane—Dyspepsia—Acetazolamide—glaucoma	0.00118	0.00131	CcSEcCtD
Mitotane—Headache—Latanoprost—glaucoma	0.00118	0.0013	CcSEcCtD
Mitotane—Skin disorder—Brinzolamide—glaucoma	0.00118	0.0013	CcSEcCtD
Mitotane—Anorexia—Dorzolamide—glaucoma	0.00117	0.0013	CcSEcCtD
Mitotane—Confusional state—Pilocarpine—glaucoma	0.00117	0.0013	CcSEcCtD
Mitotane—Decreased appetite—Acetazolamide—glaucoma	0.00117	0.00129	CcSEcCtD
Mitotane—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00116	0.00129	CcSEcCtD
Mitotane—Paraesthesia—Brimonidine—glaucoma	0.00116	0.00128	CcSEcCtD
Mitotane—Infection—Pilocarpine—glaucoma	0.00116	0.00128	CcSEcCtD
Mitotane—Nausea—Methazolamide—glaucoma	0.00115	0.00128	CcSEcCtD
Mitotane—Hypotension—Dorzolamide—glaucoma	0.00115	0.00128	CcSEcCtD
Mitotane—Somnolence—Brimonidine—glaucoma	0.00115	0.00127	CcSEcCtD
Mitotane—Mental disorder—Clonidine—glaucoma	0.00115	0.00127	CcSEcCtD
Mitotane—Hypotension—Travoprost—glaucoma	0.00115	0.00127	CcSEcCtD
Mitotane—Shock—Pilocarpine—glaucoma	0.00114	0.00127	CcSEcCtD
Mitotane—Thrombocytopenia—Pilocarpine—glaucoma	0.00114	0.00126	CcSEcCtD
Mitotane—Dyspepsia—Brimonidine—glaucoma	0.00114	0.00126	CcSEcCtD
Mitotane—Hypotension—Brinzolamide—glaucoma	0.00113	0.00125	CcSEcCtD
Mitotane—Gastrointestinal disorder—Brimonidine—glaucoma	0.00111	0.00123	CcSEcCtD
Mitotane—Anorexia—Pilocarpine—glaucoma	0.00111	0.00123	CcSEcCtD
Mitotane—Feeling abnormal—Acetazolamide—glaucoma	0.00111	0.00123	CcSEcCtD
Mitotane—Hypersensitivity—Apraclonidine—glaucoma	0.00111	0.00123	CcSEcCtD
Mitotane—Paraesthesia—Dorzolamide—glaucoma	0.00111	0.00123	CcSEcCtD
Mitotane—Pain—Brimonidine—glaucoma	0.0011	0.00122	CcSEcCtD
Mitotane—Visual impairment—Betaxolol—glaucoma	0.0011	0.00122	CcSEcCtD
Mitotane—Somnolence—Dorzolamide—glaucoma	0.00109	0.00121	CcSEcCtD
Mitotane—Hypotension—Pilocarpine—glaucoma	0.00109	0.00121	CcSEcCtD
Mitotane—Paraesthesia—Brinzolamide—glaucoma	0.00109	0.00121	CcSEcCtD
Mitotane—Dyspepsia—Dorzolamide—glaucoma	0.00108	0.0012	CcSEcCtD
Mitotane—Dyspepsia—Travoprost—glaucoma	0.00108	0.0012	CcSEcCtD
Mitotane—Asthenia—Apraclonidine—glaucoma	0.00108	0.00119	CcSEcCtD
Mitotane—Somnolence—Brinzolamide—glaucoma	0.00108	0.00119	CcSEcCtD
Mitotane—Vision blurred—Clonidine—glaucoma	0.00107	0.00119	CcSEcCtD
Mitotane—Decreased appetite—Dorzolamide—glaucoma	0.00107	0.00119	CcSEcCtD
Mitotane—Tremor—Clonidine—glaucoma	0.00107	0.00118	CcSEcCtD
Mitotane—Dyspepsia—Brinzolamide—glaucoma	0.00107	0.00118	CcSEcCtD
Mitotane—Eye disorder—Betaxolol—glaucoma	0.00106	0.00118	CcSEcCtD
Mitotane—Body temperature increased—Acetazolamide—glaucoma	0.00106	0.00118	CcSEcCtD
Mitotane—Gastrointestinal disorder—Travoprost—glaucoma	0.00106	0.00117	CcSEcCtD
Mitotane—Flushing—Betaxolol—glaucoma	0.00106	0.00117	CcSEcCtD
Mitotane—Pain—Dorzolamide—glaucoma	0.00105	0.00117	CcSEcCtD
Mitotane—Decreased appetite—Brinzolamide—glaucoma	0.00105	0.00117	CcSEcCtD
Mitotane—Pain—Travoprost—glaucoma	0.00105	0.00116	CcSEcCtD
Mitotane—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00105	0.00116	CcSEcCtD
Mitotane—Paraesthesia—Pilocarpine—glaucoma	0.00104	0.00116	CcSEcCtD
Mitotane—Asthenia—Bimatoprost—glaucoma	0.00104	0.00116	CcSEcCtD
Mitotane—Pain—Brinzolamide—glaucoma	0.00104	0.00115	CcSEcCtD
Mitotane—Somnolence—Pilocarpine—glaucoma	0.00103	0.00115	CcSEcCtD
Mitotane—Angiopathy—Betaxolol—glaucoma	0.00103	0.00115	CcSEcCtD
Mitotane—Diarrhoea—Apraclonidine—glaucoma	0.00103	0.00114	CcSEcCtD
Mitotane—Dyspepsia—Pilocarpine—glaucoma	0.00102	0.00114	CcSEcCtD
Mitotane—Feeling abnormal—Dorzolamide—glaucoma	0.00101	0.00112	CcSEcCtD
Mitotane—Decreased appetite—Pilocarpine—glaucoma	0.00101	0.00112	CcSEcCtD
Mitotane—Feeling abnormal—Travoprost—glaucoma	0.00101	0.00112	CcSEcCtD
Mitotane—Gastrointestinal disorder—Pilocarpine—glaucoma	0.001	0.00111	CcSEcCtD
Mitotane—Feeling abnormal—Brinzolamide—glaucoma	0.000998	0.00111	CcSEcCtD
Mitotane—Mental disorder—Betaxolol—glaucoma	0.000998	0.00111	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTT1—glaucoma	0.000996	0.0102	CbGpPWpGaD
Mitotane—Pain—Pilocarpine—glaucoma	0.000995	0.0011	CcSEcCtD
Mitotane—Dizziness—Apraclonidine—glaucoma	0.000993	0.0011	CcSEcCtD
Mitotane—Malnutrition—Betaxolol—glaucoma	0.000991	0.0011	CcSEcCtD
Mitotane—Body temperature increased—Dorzolamide—glaucoma	0.000974	0.00108	CcSEcCtD
Mitotane—Dysgeusia—Betaxolol—glaucoma	0.000971	0.00108	CcSEcCtD
Mitotane—Asthenia—Acetazolamide—glaucoma	0.000964	0.00107	CcSEcCtD
Mitotane—Dizziness—Bimatoprost—glaucoma	0.000963	0.00107	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000963	0.00107	CcSEcCtD
Mitotane—Feeling abnormal—Pilocarpine—glaucoma	0.000959	0.00106	CcSEcCtD
Mitotane—FDX1—Metabolism—CA1—glaucoma	0.000957	0.00978	CbGpPWpGaD
Mitotane—Vomiting—Apraclonidine—glaucoma	0.000955	0.00106	CcSEcCtD
Mitotane—Hypersensitivity—Brimonidine—glaucoma	0.00095	0.00105	CcSEcCtD
Mitotane—Dermatitis—Apraclonidine—glaucoma	0.000946	0.00105	CcSEcCtD
Mitotane—Headache—Apraclonidine—glaucoma	0.000941	0.00104	CcSEcCtD
Mitotane—Confusional state—Clonidine—glaucoma	0.000937	0.00104	CcSEcCtD
Mitotane—Vision blurred—Betaxolol—glaucoma	0.000934	0.00104	CcSEcCtD
Mitotane—Tremor—Betaxolol—glaucoma	0.000929	0.00103	CcSEcCtD
Mitotane—FDX1—Metabolism—CTSA—glaucoma	0.000927	0.00947	CbGpPWpGaD
Mitotane—Asthenia—Brimonidine—glaucoma	0.000925	0.00103	CcSEcCtD
Mitotane—Infection—Clonidine—glaucoma	0.000923	0.00102	CcSEcCtD
Mitotane—Body temperature increased—Pilocarpine—glaucoma	0.00092	0.00102	CcSEcCtD
Mitotane—Diarrhoea—Acetazolamide—glaucoma	0.000919	0.00102	CcSEcCtD
Mitotane—Rash—Bimatoprost—glaucoma	0.000918	0.00102	CcSEcCtD
Mitotane—Dermatitis—Bimatoprost—glaucoma	0.000917	0.00102	CcSEcCtD
Mitotane—Anaemia—Betaxolol—glaucoma	0.000916	0.00102	CcSEcCtD
Mitotane—Shock—Clonidine—glaucoma	0.000914	0.00101	CcSEcCtD
Mitotane—Connective tissue disorder—Timolol—glaucoma	0.000914	0.00101	CcSEcCtD
Mitotane—Headache—Bimatoprost—glaucoma	0.000912	0.00101	CcSEcCtD
Mitotane—Nervous system disorder—Clonidine—glaucoma	0.000911	0.00101	CcSEcCtD
Mitotane—Thrombocytopenia—Clonidine—glaucoma	0.00091	0.00101	CcSEcCtD
Mitotane—Hypersensitivity—Dorzolamide—glaucoma	0.000907	0.00101	CcSEcCtD
Mitotane—Hypersensitivity—Travoprost—glaucoma	0.000903	0.001	CcSEcCtD
Mitotane—Skin disorder—Clonidine—glaucoma	0.000903	0.001	CcSEcCtD
Mitotane—Visual impairment—Timolol—glaucoma	0.000897	0.000994	CcSEcCtD
Mitotane—Nausea—Apraclonidine—glaucoma	0.000892	0.000989	CcSEcCtD
Mitotane—Hypersensitivity—Brinzolamide—glaucoma	0.000892	0.000989	CcSEcCtD
Mitotane—Vertigo—Betaxolol—glaucoma	0.000891	0.000987	CcSEcCtD
Mitotane—Dizziness—Acetazolamide—glaucoma	0.000889	0.000985	CcSEcCtD
Mitotane—Anorexia—Clonidine—glaucoma	0.000886	0.000982	CcSEcCtD
Mitotane—Asthenia—Dorzolamide—glaucoma	0.000884	0.000979	CcSEcCtD
Mitotane—Asthenia—Travoprost—glaucoma	0.00088	0.000975	CcSEcCtD
Mitotane—FDX1—Metabolism—CA2—glaucoma	0.000875	0.00895	CbGpPWpGaD
Mitotane—Eye disorder—Timolol—glaucoma	0.000869	0.000964	CcSEcCtD
Mitotane—Asthenia—Brinzolamide—glaucoma	0.000869	0.000963	CcSEcCtD
Mitotane—Hypotension—Clonidine—glaucoma	0.000868	0.000963	CcSEcCtD
Mitotane—Nausea—Bimatoprost—glaucoma	0.000865	0.000959	CcSEcCtD
Mitotane—Hypersensitivity—Pilocarpine—glaucoma	0.000857	0.00095	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000856	0.00874	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000856	0.00874	CbGpPWpGaD
Mitotane—Vomiting—Acetazolamide—glaucoma	0.000854	0.000947	CcSEcCtD
Mitotane—Dizziness—Brimonidine—glaucoma	0.000853	0.000945	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—GSTT1—glaucoma	0.000852	0.00871	CbGpPWpGaD
Mitotane—Angiopathy—Timolol—glaucoma	0.000844	0.000936	CcSEcCtD
Mitotane—Diarrhoea—Dorzolamide—glaucoma	0.000843	0.000934	CcSEcCtD
Mitotane—Headache—Acetazolamide—glaucoma	0.000842	0.000933	CcSEcCtD
Mitotane—Diarrhoea—Travoprost—glaucoma	0.000839	0.00093	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000838	0.000929	CcSEcCtD
Mitotane—Asthenia—Pilocarpine—glaucoma	0.000835	0.000926	CcSEcCtD
Mitotane—Paraesthesia—Clonidine—glaucoma	0.000834	0.000925	CcSEcCtD
Mitotane—Diarrhoea—Brinzolamide—glaucoma	0.000828	0.000918	CcSEcCtD
Mitotane—Somnolence—Clonidine—glaucoma	0.000826	0.000916	CcSEcCtD
Mitotane—Confusional state—Betaxolol—glaucoma	0.000816	0.000904	CcSEcCtD
Mitotane—Mental disorder—Timolol—glaucoma	0.000815	0.000903	CcSEcCtD
Mitotane—Dizziness—Dorzolamide—glaucoma	0.000814	0.000903	CcSEcCtD
Mitotane—Rash—Brimonidine—glaucoma	0.000813	0.000901	CcSEcCtD
Mitotane—Dermatitis—Brimonidine—glaucoma	0.000812	0.0009	CcSEcCtD
Mitotane—Dizziness—Travoprost—glaucoma	0.000811	0.000899	CcSEcCtD
Mitotane—Malnutrition—Timolol—glaucoma	0.00081	0.000898	CcSEcCtD
Mitotane—Headache—Brimonidine—glaucoma	0.000808	0.000896	CcSEcCtD
Mitotane—Decreased appetite—Clonidine—glaucoma	0.000808	0.000895	CcSEcCtD
Mitotane—Infection—Betaxolol—glaucoma	0.000804	0.000891	CcSEcCtD
Mitotane—Gastrointestinal disorder—Clonidine—glaucoma	0.000802	0.000889	CcSEcCtD
Mitotane—Dizziness—Brinzolamide—glaucoma	0.000801	0.000888	CcSEcCtD
Mitotane—Nausea—Acetazolamide—glaucoma	0.000798	0.000885	CcSEcCtD
Mitotane—Diarrhoea—Pilocarpine—glaucoma	0.000796	0.000883	CcSEcCtD
Mitotane—Shock—Betaxolol—glaucoma	0.000796	0.000882	CcSEcCtD
Mitotane—Pain—Clonidine—glaucoma	0.000795	0.000881	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—CYP1B1—glaucoma	0.000794	0.00811	CbGpPWpGaD
Mitotane—Nervous system disorder—Betaxolol—glaucoma	0.000793	0.00088	CcSEcCtD
Mitotane—Dysgeusia—Timolol—glaucoma	0.000793	0.000879	CcSEcCtD
Mitotane—Thrombocytopenia—Betaxolol—glaucoma	0.000792	0.000878	CcSEcCtD
Mitotane—Skin disorder—Betaxolol—glaucoma	0.000786	0.000871	CcSEcCtD
Mitotane—Vomiting—Dorzolamide—glaucoma	0.000783	0.000868	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—CYP1B1—glaucoma	0.000783	0.008	CbGpPWpGaD
Mitotane—Rash—Dorzolamide—glaucoma	0.000777	0.000861	CcSEcCtD
Mitotane—Dermatitis—Dorzolamide—glaucoma	0.000776	0.00086	CcSEcCtD
Mitotane—Rash—Travoprost—glaucoma	0.000773	0.000857	CcSEcCtD
Mitotane—Dermatitis—Travoprost—glaucoma	0.000772	0.000856	CcSEcCtD
Mitotane—Headache—Dorzolamide—glaucoma	0.000772	0.000855	CcSEcCtD
Mitotane—Anorexia—Betaxolol—glaucoma	0.000771	0.000855	CcSEcCtD
Mitotane—Vomiting—Brinzolamide—glaucoma	0.00077	0.000853	CcSEcCtD
Mitotane—Dizziness—Pilocarpine—glaucoma	0.00077	0.000853	CcSEcCtD
Mitotane—Headache—Travoprost—glaucoma	0.000768	0.000852	CcSEcCtD
Mitotane—Nausea—Brimonidine—glaucoma	0.000766	0.000849	CcSEcCtD
Mitotane—Feeling abnormal—Clonidine—glaucoma	0.000766	0.000849	CcSEcCtD
Mitotane—Rash—Brinzolamide—glaucoma	0.000763	0.000846	CcSEcCtD
Mitotane—Vision blurred—Timolol—glaucoma	0.000763	0.000846	CcSEcCtD
Mitotane—Dermatitis—Brinzolamide—glaucoma	0.000763	0.000845	CcSEcCtD
Mitotane—Headache—Brinzolamide—glaucoma	0.000759	0.000841	CcSEcCtD
Mitotane—Hypotension—Betaxolol—glaucoma	0.000756	0.000838	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000741	0.00758	CbGpPWpGaD
Mitotane—Vomiting—Pilocarpine—glaucoma	0.00074	0.00082	CcSEcCtD
Mitotane—Body temperature increased—Clonidine—glaucoma	0.000735	0.000814	CcSEcCtD
Mitotane—Rash—Pilocarpine—glaucoma	0.000734	0.000813	CcSEcCtD
Mitotane—Dermatitis—Pilocarpine—glaucoma	0.000733	0.000813	CcSEcCtD
Mitotane—Nausea—Dorzolamide—glaucoma	0.000732	0.000811	CcSEcCtD
Mitotane—Headache—Pilocarpine—glaucoma	0.000729	0.000808	CcSEcCtD
Mitotane—Nausea—Travoprost—glaucoma	0.000728	0.000807	CcSEcCtD
Mitotane—Vertigo—Timolol—glaucoma	0.000728	0.000807	CcSEcCtD
Mitotane—Paraesthesia—Betaxolol—glaucoma	0.000727	0.000805	CcSEcCtD
Mitotane—Nausea—Brinzolamide—glaucoma	0.000719	0.000797	CcSEcCtD
Mitotane—Dyspepsia—Betaxolol—glaucoma	0.000712	0.000789	CcSEcCtD
Mitotane—Decreased appetite—Betaxolol—glaucoma	0.000703	0.00078	CcSEcCtD
Mitotane—Hypertension—Timolol—glaucoma	0.000699	0.000775	CcSEcCtD
Mitotane—Gastrointestinal disorder—Betaxolol—glaucoma	0.000699	0.000774	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CA5A—glaucoma	0.000698	0.00714	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NARFL—glaucoma	0.000698	0.00714	CbGpPWpGaD
Mitotane—Pain—Betaxolol—glaucoma	0.000692	0.000767	CcSEcCtD
Mitotane—Nausea—Pilocarpine—glaucoma	0.000691	0.000766	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000685	0.000759	CcSEcCtD
Mitotane—Hypersensitivity—Clonidine—glaucoma	0.000685	0.000759	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—CYP1B1—glaucoma	0.000679	0.00694	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—CYP1B1—glaucoma	0.00067	0.00684	CbGpPWpGaD
Mitotane—Asthenia—Clonidine—glaucoma	0.000667	0.000739	CcSEcCtD
Mitotane—Feeling abnormal—Betaxolol—glaucoma	0.000667	0.000739	CcSEcCtD
Mitotane—Confusional state—Timolol—glaucoma	0.000666	0.000739	CcSEcCtD
Mitotane—Infection—Timolol—glaucoma	0.000657	0.000728	CcSEcCtD
Mitotane—Shock—Timolol—glaucoma	0.00065	0.000721	CcSEcCtD
Mitotane—Nervous system disorder—Timolol—glaucoma	0.000648	0.000719	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—NOS3—glaucoma	0.000645	0.00659	CbGpPWpGaD
Mitotane—Skin disorder—Timolol—glaucoma	0.000642	0.000712	CcSEcCtD
Mitotane—Body temperature increased—Betaxolol—glaucoma	0.00064	0.000709	CcSEcCtD
Mitotane—Diarrhoea—Clonidine—glaucoma	0.000636	0.000705	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTM1—glaucoma	0.000635	0.00648	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000634	0.00648	CbGpPWpGaD
Mitotane—Anorexia—Timolol—glaucoma	0.00063	0.000698	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—GSTM1—glaucoma	0.000626	0.0064	CbGpPWpGaD
Mitotane—Hypotension—Timolol—glaucoma	0.000618	0.000685	CcSEcCtD
Mitotane—FDX1—Metabolism—TXN—glaucoma	0.000617	0.0063	CbGpPWpGaD
Mitotane—Dizziness—Clonidine—glaucoma	0.000615	0.000681	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CA5A—glaucoma	0.000597	0.0061	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NARFL—glaucoma	0.000597	0.0061	CbGpPWpGaD
Mitotane—Hypersensitivity—Betaxolol—glaucoma	0.000596	0.000661	CcSEcCtD
Mitotane—Paraesthesia—Timolol—glaucoma	0.000594	0.000658	CcSEcCtD
Mitotane—Vomiting—Clonidine—glaucoma	0.000591	0.000655	CcSEcCtD
Mitotane—Somnolence—Timolol—glaucoma	0.000588	0.000651	CcSEcCtD
Mitotane—Rash—Clonidine—glaucoma	0.000586	0.00065	CcSEcCtD
Mitotane—Dermatitis—Clonidine—glaucoma	0.000585	0.000649	CcSEcCtD
Mitotane—Headache—Clonidine—glaucoma	0.000582	0.000645	CcSEcCtD
Mitotane—Dyspepsia—Timolol—glaucoma	0.000582	0.000645	CcSEcCtD
Mitotane—Asthenia—Betaxolol—glaucoma	0.00058	0.000643	CcSEcCtD
Mitotane—Decreased appetite—Timolol—glaucoma	0.000575	0.000637	CcSEcCtD
Mitotane—Gastrointestinal disorder—Timolol—glaucoma	0.000571	0.000633	CcSEcCtD
Mitotane—Pain—Timolol—glaucoma	0.000565	0.000627	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000563	0.00575	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000558	0.0057	CbGpPWpGaD
Mitotane—Diarrhoea—Betaxolol—glaucoma	0.000554	0.000614	CcSEcCtD
Mitotane—Nausea—Clonidine—glaucoma	0.000552	0.000612	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—NOS3—glaucoma	0.000552	0.00564	CbGpPWpGaD
Mitotane—Feeling abnormal—Timolol—glaucoma	0.000545	0.000604	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—GSTM1—glaucoma	0.000543	0.00555	CbGpPWpGaD
Mitotane—CYP11A1—Metapathway biotransformation—GSTM1—glaucoma	0.000535	0.00547	CbGpPWpGaD
Mitotane—Dizziness—Betaxolol—glaucoma	0.000535	0.000593	CcSEcCtD
Mitotane—Body temperature increased—Timolol—glaucoma	0.000523	0.000579	CcSEcCtD
Mitotane—Vomiting—Betaxolol—glaucoma	0.000514	0.00057	CcSEcCtD
Mitotane—Rash—Betaxolol—glaucoma	0.00051	0.000565	CcSEcCtD
Mitotane—Dermatitis—Betaxolol—glaucoma	0.00051	0.000565	CcSEcCtD
Mitotane—Headache—Betaxolol—glaucoma	0.000507	0.000562	CcSEcCtD
Mitotane—Hypersensitivity—Timolol—glaucoma	0.000487	0.00054	CcSEcCtD
Mitotane—Nausea—Betaxolol—glaucoma	0.000481	0.000533	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTT1—glaucoma	0.000478	0.00489	CbGpPWpGaD
Mitotane—Asthenia—Timolol—glaucoma	0.000474	0.000526	CcSEcCtD
Mitotane—Diarrhoea—Timolol—glaucoma	0.000452	0.000501	CcSEcCtD
Mitotane—Dizziness—Timolol—glaucoma	0.000437	0.000484	CcSEcCtD
Mitotane—Vomiting—Timolol—glaucoma	0.00042	0.000466	CcSEcCtD
Mitotane—Rash—Timolol—glaucoma	0.000417	0.000462	CcSEcCtD
Mitotane—Dermatitis—Timolol—glaucoma	0.000416	0.000462	CcSEcCtD
Mitotane—Headache—Timolol—glaucoma	0.000414	0.000459	CcSEcCtD
Mitotane—Nausea—Timolol—glaucoma	0.000393	0.000435	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000386	0.00394	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP1B1—glaucoma	0.000381	0.00389	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ABCA1—glaucoma	0.000381	0.00389	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CA1—glaucoma	0.000341	0.00348	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CTSA—glaucoma	0.00033	0.00337	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CA2—glaucoma	0.000312	0.00319	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000305	0.00311	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000305	0.00311	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GSTM1—glaucoma	0.000305	0.00311	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CA1—glaucoma	0.000292	0.00298	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CTSA—glaucoma	0.000282	0.00289	CbGpPWpGaD
Mitotane—FDX1—Metabolism—MTHFR—glaucoma	0.000269	0.00275	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CA2—glaucoma	0.000267	0.00273	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000261	0.00266	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000261	0.00266	CbGpPWpGaD
Mitotane—FDX1—Metabolism—APOE—glaucoma	0.000251	0.00256	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CAV1—glaucoma	0.000248	0.00254	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TXN—glaucoma	0.00022	0.00225	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.0002	0.00205	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000199	0.00203	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TXN—glaucoma	0.000188	0.00192	CbGpPWpGaD
Mitotane—FDX1—Metabolism—NOS3—glaucoma	0.000188	0.00192	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTGS2—glaucoma	0.000172	0.00175	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000172	0.00175	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTT1—glaucoma	0.00017	0.00174	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.00017	0.00174	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTT1—glaucoma	0.000146	0.00149	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000137	0.0014	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ABCA1—glaucoma	0.000136	0.00139	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1B1—glaucoma	0.000136	0.00139	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000118	0.0012	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCA1—glaucoma	0.000116	0.00119	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1B1—glaucoma	0.000116	0.00119	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTM1—glaucoma	0.000109	0.00111	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—MTHFR—glaucoma	9.59e-05	0.00098	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTM1—glaucoma	9.28e-05	0.000949	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—APOE—glaucoma	8.93e-05	0.000912	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CAV1—glaucoma	8.85e-05	0.000904	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—MTHFR—glaucoma	8.2e-05	0.000838	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—APOE—glaucoma	7.64e-05	0.000781	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CAV1—glaucoma	7.57e-05	0.000773	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NOS3—glaucoma	6.69e-05	0.000684	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTGS2—glaucoma	6.12e-05	0.000625	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NOS3—glaucoma	5.72e-05	0.000585	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGS2—glaucoma	5.23e-05	0.000535	CbGpPWpGaD
